Monday, January 24, 2011

Lyme Disease Vaccine: Lessons Learned


I am going to keep this post brief.

Deer Tick: a vector of Lyme Disease
There is scholarly perspective in Clinical Infectious Diseases on Lyme Disease vaccination- lessons learned. Unlike most other infectious diseases, there is a tremendous amount of misunderstanding, shady science, advocacy groups, and emotion associated with Lyme Disease.  Despite Infectious Diseases Society of America (IDSA)  guidelines , based on best available evidence, certain physicians and advocacy groups choose to adhere to different diagnostic and treatment perspectives. For example, I refer you to International Lyme and Associated Diseases Society (ILADS).

With a strong anti-vaccine sentiment and history of class action lawsuits in the USA, a complicated vaccine administration schedule and low public demand for the vaccine, the LYMERix manufacturer voluntarily terminated vaccine production of the vaccine in 2002.

To quote the manuscript- ‘‘.media focus and swings of public opinion can pre-empt the scientific weighing of risks and benefits in determining success or failure’’

Many hurdles remain for a new Lyme Disease vaccine, not the least of which is interpreting and reporting the science in an informed, clear and unemotional fashion.

Good luck with that.